1. Home
  2. EYPT vs CCNE Comparison

EYPT vs CCNE Comparison

Compare EYPT & CCNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EYPT
  • CCNE
  • Stock Information
  • Founded
  • EYPT 1987
  • CCNE 1865
  • Country
  • EYPT United States
  • CCNE United States
  • Employees
  • EYPT N/A
  • CCNE N/A
  • Industry
  • EYPT Biotechnology: Laboratory Analytical Instruments
  • CCNE Major Banks
  • Sector
  • EYPT Industrials
  • CCNE Finance
  • Exchange
  • EYPT Nasdaq
  • CCNE Nasdaq
  • Market Cap
  • EYPT 594.5M
  • CCNE 595.8M
  • IPO Year
  • EYPT 2005
  • CCNE N/A
  • Fundamental
  • Price
  • EYPT $8.12
  • CCNE $26.87
  • Analyst Decision
  • EYPT Strong Buy
  • CCNE Hold
  • Analyst Count
  • EYPT 8
  • CCNE 1
  • Target Price
  • EYPT $27.29
  • CCNE $30.00
  • AVG Volume (30 Days)
  • EYPT 918.1K
  • CCNE 46.5K
  • Earning Date
  • EYPT 11-07-2024
  • CCNE 01-21-2025
  • Dividend Yield
  • EYPT N/A
  • CCNE 2.59%
  • EPS Growth
  • EYPT N/A
  • CCNE N/A
  • EPS
  • EYPT N/A
  • CCNE 2.33
  • Revenue
  • EYPT $45,713,000.00
  • CCNE $216,515,000.00
  • Revenue This Year
  • EYPT N/A
  • CCNE N/A
  • Revenue Next Year
  • EYPT N/A
  • CCNE $8.80
  • P/E Ratio
  • EYPT N/A
  • CCNE $11.53
  • Revenue Growth
  • EYPT 7.50
  • CCNE N/A
  • 52 Week Low
  • EYPT $7.21
  • CCNE $17.74
  • 52 Week High
  • EYPT $30.99
  • CCNE $29.29
  • Technical
  • Relative Strength Index (RSI)
  • EYPT 41.68
  • CCNE 48.49
  • Support Level
  • EYPT $7.21
  • CCNE $27.00
  • Resistance Level
  • EYPT $8.21
  • CCNE $27.67
  • Average True Range (ATR)
  • EYPT 0.49
  • CCNE 0.59
  • MACD
  • EYPT -0.02
  • CCNE -0.18
  • Stochastic Oscillator
  • EYPT 42.82
  • CCNE 25.00

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

About CCNE CNB Financial Corporation

CNB Financial Corp is providing integrated financial solutions, which create value for both consumers and businesses. These solutions encompass deposit accounts, private banking, real estate, commercial, industrial, residential and consumer loans and lines of credit, credit cards, treasury services, online banking, mobile banking, merchant credit card processing, remote deposit and accounts receivable handling. In addition, the corporation provides wealth and asset management services, retirement plans and other employee benefit plans.

Share on Social Networks: